Tenderwize
Retour à la recherche

Ibuprofen 400 mg and 600 mg (prescription, non-retarded)

AOK Sachsen - Anhalt·Magdeburg, Germany·Deadline Mar 30, 2027 · 214 days left·Open·Supplies
Structured notice only
Titre original de l'avis

Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Ibuprofen (ATC: M01AE01 - verschreibungspflichtig, in nicht retardierter Darreichungsform mit den Wirkstärken 400mg und 600mg)

55/100

Score d'opportunité

Needs reviewLow complexity
SuppliesOpen
Pourquoi ce score ?

Opportunité

55 / 100

Complexité

20 / 100

Facteurs de risque

No volume commitment; the agreement only provides a framework for discounts but does not guarantee any sales.

This is not a public procurement under EU law. Legal protection mechanisms (e.g., suspension periods) are only cited vo...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Supplies contract
  • 1 lot
  • Duration 2 YEAR
  • Supply of Ibuprofen 400 mg and 600 mg prescription-only non-retarded finished medicinal products under non-exclusive discount agreements
  • Contracting with the statutory health insurance fund AOK Sachsen-Anhalt
Afficher le résumé complet

This is a non-exclusive open-house model for discount agreements under German social law (§130a SGB V) for Ibuprofen 400mg and 600mg (prescription, non-retarded). Any eligible pharmaceutical company can join at any time until 31 March 2027, with contracts starting from 1 June 2025 and lasting maximum 24 months (until 31 May 2027). The publication is voluntary for transparency; it is not a public procurement under EU law. No estimated value is stated, and no award criteria weights are provided. Submission is mainly by post, but electronically signed PDFs via email are also accepted.

Risques

No volume commitment; the agreement only provides a framework for discounts but does not guarantee any sales.

This is not a public procurement under EU law. Legal protection mechanisms (e.g., suspension periods) are only cited vo...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • No exclusivity; each qualifying company gets a contract on identical terms
  • Contract period: max 24 months, ends 31 May 2027, starting no earlier than 1 June 2025

Eligibility

  • Eligible: any pharmaceutical company or consortium that meets participation requirements under §130a SGB V

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

No award criteria specified; all eligible companies are accepted without competition.

Acheteur

Localisation

Magdeburg, DEU

Profil acheteur

Ouvrir le profil

Identifiant

DE258393558

Activité

Health

Lots (1)

LOT-0001

Ibuprofen 400 mg and 600 mg (prescription, non-retarded)

Non-exclusive discount agreements for Ibuprofen finished medicinal products with active substance Ibuprofen (ATC M01AE01) in strengths 400mg and 600mg, prescription-only, non-retarded form. Open to all qualifying pharmaceutical companies. No exclusivity. Contract duration max 24 months from earliest start 01.06.2025 to 31.05.2027.

SuppliesEU fundedElectronic submission

Localisation

DEE03, Germany

Durée

2 YEAR

Catégorie

Pharmaceutical products

Critères d'attribution

No award criteria specified; all eligible companies are accepted without competition.

Date limite

Deadline Mar 30, 2027

Détails de la procédure

Date de publication
09 Apr 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
233889-2025

Documents (1)

Appels d'offres similaires